Consolidation treatment with Tiaogan-Buxu-Jiedu granule (Traditional Chinese Medicine compound) plus entecavir reduces virological relapse following entecavir withdrawal in Chinese patients with chronic hepatitis B: a randomized, controlled trial
机构：[1]Beijing Univ Chinese Med, Dongzhimen Hosp, Hepatol, Beijing, Peoples R China[2]Beijing Univ Chinese Med, Liver Dis Acad Tradit Chinese Med, Beijing, Peoples R China[3]Shenzhen Tradit Chinese Med Hosp, Hepatol, Shenzhen, Peoples R China[4]Chongqing Tradit Chinese Med Hosp, Hepatol, Chongqing, Peoples R China[5]Guangzhou Univ Chinese Med, Hepatol, Affiliated Hosp 2, Guangzhou, Peoples R China广东省中医院[6]Liaoning Hosp Tradit Chinese Med, Hepatol, Shenyang, Peoples R China[7]Beijing Ditan Hosp, Beijing, Peoples R China[8]Guangxi Univ Chinese Med, Affiliated Hosp 1, Nanning, Peoples R China[9]Fujian Med Univ, Mengchao Hepatobiliary Hosp, Hepatol, Fuzhou, Peoples R China[10]Shaanxi Hosp Tradit Chinese Med, Hepatol, Xian, Peoples R China[11]Sixth Peoples Hosp Shenyang, Shanghai, Peoples R China[12]Third Peoples Hosp Shenzhen, Hepatol, Shenzhen, Peoples R China[13]Publ Hlth Clin Ctr Chengdu, Hepatol, Chengdu, Peoples R China[14]Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Luzhou, Peoples R China[15]Fifth Med Ctr Peoples Liberat Army China, Hepatol, Beijing, Peoples R China[16]Shandong Hosp Tradit Chinese Med, Hepatol, Jinan, Peoples R China[17]Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Hepatol, Shanghai, Peoples R China[18]Beijing Chinese Med Hosp, Beijing, Peoples R China[19]Second Peoples Hosp Tianjin, Tianjin, Peoples R China[20]Shandong Univ, Hosp 2, Jinan, Peoples R China
第一作者机构：[1]Beijing Univ Chinese Med, Dongzhimen Hosp, Hepatol, Beijing, Peoples R China[2]Beijing Univ Chinese Med, Liver Dis Acad Tradit Chinese Med, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Li Xiaoke,Qiu Mei,Huang Yi,et al.Consolidation treatment with Tiaogan-Buxu-Jiedu granule (Traditional Chinese Medicine compound) plus entecavir reduces virological relapse following entecavir withdrawal in Chinese patients with chronic hepatitis B: a randomized, controlled trial[J].JOURNAL OF HEPATOLOGY.2023,78:S1157-S1158.
APA：
Li, Xiaoke,Qiu, Mei,Huang, Yi,Xiao, Huanming,Lu, Bingjiu...&Ye, Yong'an.(2023).Consolidation treatment with Tiaogan-Buxu-Jiedu granule (Traditional Chinese Medicine compound) plus entecavir reduces virological relapse following entecavir withdrawal in Chinese patients with chronic hepatitis B: a randomized, controlled trial.JOURNAL OF HEPATOLOGY,78,
MLA：
Li, Xiaoke,et al."Consolidation treatment with Tiaogan-Buxu-Jiedu granule (Traditional Chinese Medicine compound) plus entecavir reduces virological relapse following entecavir withdrawal in Chinese patients with chronic hepatitis B: a randomized, controlled trial".JOURNAL OF HEPATOLOGY 78.(2023):S1157-S1158
医学